EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Age and gender effects on molecular responses in chronic myeloid leukemia patients by first-line treatment: an Italian CML network cohort study

Massimo Breccia, Valentina Giai, Tiziana Rosso, Patrizia Pregno, Fausto Castagnetti, Massimiliano Bonifacio, Isabella Capodanno, Mario Tiribelli, Fabio Stagno, Giovanni Caocci, Antonella Gozzini, Andrea Patriarca und 13 weitere

Annals of Hematology · 2026

DOI: 10.1007/s00277-026-07012-1 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Annals of Hematology, 2026. Verfasst von Massimo Breccia und 24 weiteren Autor:innen. Beteiligte Einrichtung: Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Via Benevento 6, Rome, 00161, Italy. b…. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Protein Kinase Inhibitors. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among prognostic factors influencing the achievement of molecular responses in chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors (TKIs), age has been suggested with contrasting results, while the role of gender is still uncertain. A large cohort of 1,394 newly diagnosed CML patients was analyzed by data collected in the Italian CML Network, evaluating the effect of age and gender on the probability of deep molecular responses (DMR). With a median follow-up of 5 years, female patients showed a higher rate of DMR as compared to males. The effect, constant over time, was more evident with imatinib and dasatinib. Indeed, age did not influence the probability of DMR, when considered overall or stratified according to the type of TKI. In a real-world analysis, it seems that age has no effect on DMR regardless of the TKI class, while female gender can be confirmed as significant prognostic factor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveProtein Kinase InhibitorsHumansFemaleMaleItalyCohort StudiesImatinib MesylateMiddle AgedAdultAge FactorsAgedSex FactorsDasatinibAdolescentAged, 80 and overYoung AdultFollow-Up StudiesAntineoplastic AgentsTreatment Outcome

Substanzen

Protein Kinase InhibitorsImatinib MesylateDasatinibAntineoplastic Agents

Autor:innen und Institutionen

  • Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Via Benevento 6, Rome, 00161, Italy. breccia@bce.uniroma1.it.
  • Division of Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
  • Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Torino, Italy.
  • Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Institute of Hematology "L. & A. Seràgnoli", Bologna, Italy.
  • Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Hematology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Zitieren

APA

Breccia, M., Giai, V., Rosso, T., Pregno, P., Castagnetti, F., Bonifacio, M., Capodanno, I., Tiribelli, M., Stagno, F., Caocci, G., Gozzini, A., Patriarca, A., Sorà, F., Loglisci, G., Rossi, A. R., Coppi, M. R., Miggiano, M. C., Di Raimondo, F., Galimberti, S., …, & Specchia, G. (2026). Age and gender effects on molecular responses in chronic myeloid leukemia patients by first-line treatment: an Italian CML network cohort study. Annals of Hematology. https://doi.org/10.1007/s00277-026-07012-1

Vancouver

Breccia M, Giai V, Rosso T, Pregno P, Castagnetti F, Bonifacio M, et al. Age and gender effects on molecular responses in chronic myeloid leukemia patients by first-line treatment: an Italian CML network cohort study. Annals of Hematology. 2026. doi:10.1007/s00277-026-07012-1

BibTeX
@article{Breccia2026,
  author = {Breccia, Massimo and Giai, Valentina and Rosso, Tiziana and Pregno, Patrizia and Castagnetti, Fausto and Bonifacio, Massimiliano and Capodanno, Isabella and Tiribelli, Mario and Stagno, Fabio and Caocci, Giovanni and Gozzini, Antonella and Patriarca, Andrea and Sorà, Federica and Loglisci, Giuseppina and Rossi, Antonella Russo and Coppi, Maria Rosaria and Miggiano, Maria Cristina and Di Raimondo, Francesco and Galimberti, Sara and Rosti, Gianantonio and Melillo, Lorella and Pane, Fabrizio and Saglio, Giuseppe and Ciccone, Giovannino and Specchia, Giorgina},
  title = {Age and gender effects on molecular responses in chronic myeloid leukemia patients by first-line treatment: an Italian CML network cohort study},
  journal = {Annals of Hematology},
  year = {2026},
  doi = {10.1007/s00277-026-07012-1}
}
Kostenlos starten →